In a recent study that was published in Journal of Clinical Oncology, Elizabeth A. Chrischilles, and her colleagues showed that elder people with advanced non small cell lung cancer (advanced means that the disease cannot be usually treated with surgery) are treated less often with chemotherapy in respect to the younger ones, however they face more adverse events during chemotherapy. The authors concluded that: ” Potential implicit trade-offs between symptom management and treatment toxicity should be made explicit and additionally studied. “
Journal of Clinical Oncology, Vol 28, No 4 (February 1), 2010: pp. 620-627